Post by kimi on Jun 17, 2019 2:15:43 GMT -5
Sadly many of the boardmembers, the December capital increase has apparently traumatized you. Since then you are only pursuing one thought. The management is unfit and the new savior is called VDEX.
In truth, however, the stock would probably be well below $ 1 if there had been no capital increase! There was no alternative! Mannkind has enemies and they had to send a clear signal. We now have sufficient capital by the end of 2019 - and that should be enough to further increase sales figures - unfortunately linear and not exponential. And even if there is another capital increase - so what?
Our long-term goal is sales of 10,000 scripts per week - from me only in 4 years - sales of $ 750 million per year. MCP of $10 Bill --> pps: $40-50
Unfortunately it lacks a lot of patience.
In truth, however, the stock would probably be well below $ 1 if there had been no capital increase! There was no alternative! Mannkind has enemies and they had to send a clear signal. We now have sufficient capital by the end of 2019 - and that should be enough to further increase sales figures - unfortunately linear and not exponential. And even if there is another capital increase - so what?
Our long-term goal is sales of 10,000 scripts per week - from me only in 4 years - sales of $ 750 million per year. MCP of $10 Bill --> pps: $40-50
Vdex does not solve the slightest problem - on the contrary - there is just another new problem!
Unfortunately it lacks a lot of patience.
